Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas
08/11/2022 15:39
Nov 8 (Reuters) - Oncotelic Therapeutics Inc OTLC.PK :
* ONCOTELIC INITIATES CLINICAL TRIALS EVALUATING OT-101
AGAINST
PEDIATRIC GLIOMAS
Source text for Eikon: ID:nGNX8vbrh9
Further company coverage: OTLC.PK
((reuters.briefs@thomsonreuters.com;))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas